Eagle Pharma Shares up After It Says Settlement Reached With Eli Lilly
December 13 2019 - 3:37PM
Dow Jones News
By Stephen Nakrosis
Shares of Eagle Pharmaceuticals, Inc. (EGRX) are trading higher
in Friday's market, after the company said it reached a settlement
agreement with Eli Lilly and Co. (LLY) related to Pemfexy.
At 3:01 p.m. EST, Eagle Pharma shares had risen 2.77%, to trade
at $60.78. The stock opened at $59.04 and earlier in the session
fell as low as $58.54.
According to Eagle, the agreement releases all claims by all
parties and allows for an initial entry of Pemfexy, a branded
alternative to Alitma, into the market on February 1, 2022. Under
the terms of the deal, Pemfexy will have an uncapped entry into the
market on April 1 of that year, Eagle said.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 13, 2019 15:22 ET (20:22 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024